During the past decade, International Dermatology Research, Inc. conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 32 clinical trials were completed, i.e. on average, 88.9% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 18 clinical trials were completed. i.e. 128.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "International Dermatology Research, Inc." #1 sponsor was "Amgen" with 7 trials, followed by "LEO Pharma" with 5 trials sponsored, "Provectus Pharmaceuticals" with 4 trials sponsored, "Galderma R&D" with 3 trials sponsored and "Journey Medical Corporation" with 3 trials sponsored. Other sponsors include 41 different institutions and companies that sponsored additional 41 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "International Dermatology Research, Inc." #1 collaborator was "GlaxoSmithKline" with 2 trials as a collaborator, "Symbio, LLC" with 2 trials as a collaborator, "ACM Global Laboratories" with 1 trials as a collaborator, "Athenex, Inc." with 1 trials as a collaborator and "Dermira, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "International Dermatology Research, Inc." are "Psoriasis" (16 trials), "Acne Vulgaris" (7 trials), "Plaque Psoriasis" (7 trials), "Atopic Dermatitis" (6 trials) and "Onychomycosis" (5 trials). Many other conditions were trialed in "International Dermatology Research, Inc." in a lesser frequency.

Most popular intervention types in "International Dermatology Research, Inc." are "Drug" (63 trials), "Other" (8 trials), "Device" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Vehicle" (9 trials), "Apremilast" (5 trials), "ABP 654" (2 trials) and "BMS-986165" (2 trials). Other intervention names were less common.

The vast majority of trials in "International Dermatology Research, Inc." are 68 trials for "All" genders.

Currently, there are NaN active trials in "International Dermatology Research, Inc.". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 58 completed trials in International Dermatology Research, Inc., undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in International Dermatology Research, Inc., 0 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 42 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".